Arbovirus Seroprevalence Study in Bangphae District, Ratchaburi Province, Thailand: Comparison between ELISA and a Multiplex Rapid Diagnostic Test (Chembio DPP
ELISA
RDT
Thailand
chikungunya virus
dengue virus
seroprevalence
zika virus
Journal
Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042
Informations de publication
Date de publication:
15 Nov 2022
15 Nov 2022
Historique:
received:
21
09
2022
revised:
11
11
2022
accepted:
11
11
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
25
11
2022
Statut:
epublish
Résumé
Arboviruses, particularly dengue virus (DENV), Zika virus (ZIKV), and Chikungunya virus (CHIKV), pose a growing threat to global public health. For disease burden estimation and disease control, seroprevalence studies are paramount. This study was performed to determine the prevalence of DENV, ZIKV, and CHIKV on healthy individuals aged from 1-55 years old in Bangphae district, Ratchaburi province, Thailand. Enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests (RDTs) were performed on archived samples from a dengue serological survey conducted from 2012-2015. All 2012 samples had been previously tested using an anti-DENV immunoglobulin (Ig)G ELISA, and 400 randomly selected samples stratified by age, sex, and residential area were assessed by an in-house anti-ZIKV IgG ELISA and a commercial anti-CHIKV IgG ELISA to determine virus-specific antibody levels. An RDT (Chembio DPP
Identifiants
pubmed: 36422929
pii: tropicalmed7110378
doi: 10.3390/tropicalmed7110378
pmc: PMC9692722
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University.
Références
Virol J. 2019 Oct 29;16(1):125
pubmed: 31665014
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
EClinicalMedicine. 2022 Jun 04;49:101478
pubmed: 35747186
Am J Epidemiol. 2002 Jul 1;156(1):40-51
pubmed: 12076887
Trop Med Infect Dis. 2022 Sep 21;7(10):
pubmed: 36287995
PLoS Negl Trop Dis. 2020 Aug 20;14(8):e0008282
pubmed: 32817655
Lancet Microbe. 2021 Jan;2(1):e41-e47
pubmed: 35544228
PLoS One. 2021 Sep 13;16(9):e0257205
pubmed: 34516583
Emerg Infect Dis. 2008 Aug;14(8):1232-9
pubmed: 18680646
Viruses. 2022 Feb 25;14(3):
pubmed: 35336883
PLoS Negl Trop Dis. 2011 Jun;5(6):e1197
pubmed: 21695162
Viruses. 2021 Sep 10;13(9):
pubmed: 34578383
MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):55-8
pubmed: 26820163
Popul Health Metr. 2011 Jan 10;9(1):1
pubmed: 21219615
PLoS One. 2021 Mar 10;16(3):e0247314
pubmed: 33690657
Trans R Soc Trop Med Hyg. 1954 Mar;48(2):139-45
pubmed: 13157159
MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):59-62
pubmed: 26820244
Am J Trop Med Hyg. 2020 Sep;103(3):1228-1233
pubmed: 32588813
PLoS Negl Trop Dis. 2018 Feb 9;12(2):e0006246
pubmed: 29425199
Vaccine. 2020 May 19;38(24):3989-3994
pubmed: 32336601
Epidemiol Health. 2016 Jun 16;38:e2016026
pubmed: 27336445
Novartis Found Symp. 2006;277:3-16; discussion 16-22, 71-3, 251-3
pubmed: 17319151
Int J Infect Dis. 2016 Oct;51:128-132
pubmed: 27664930
Theor Biol Med Model. 2021 Oct 3;18(1):17
pubmed: 34602095
Euro Surveill. 2014 Apr 03;19(13):
pubmed: 24721539
J Pediatr (Rio J). 2007 May;83(2 Suppl):S22-35
pubmed: 17530136
PLoS Negl Trop Dis. 2022 Jan 4;16(1):e0010021
pubmed: 34982768
Lancet Infect Dis. 2019 Apr;19(4):439-446
pubmed: 30826189
J Gen Virol. 2010 Apr;91(Pt 4):1067-76
pubmed: 19955565
PLoS Negl Trop Dis. 2010 Aug 10;4(8):e787
pubmed: 20706628